SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-07-092838
Filing Date
2007-04-27
Accepted
2007-04-27 09:42:26
Documents
6
Period of Report
2007-06-08
Effectiveness Date
2007-04-27

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 609976
3 GRAPHIC g75767g07z27.jpg GRAPHIC 15971
4 GRAPHIC g75767img001.jpg GRAPHIC 5567
5 GRAPHIC g75767img002.jpg GRAPHIC 3108
6 GRAPHIC g75767img003.jpg GRAPHIC 5669
7 GRAPHIC g75767img004.jpg GRAPHIC 6874
  Complete submission text file 0001193125-07-092838.txt   663376
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE
Type: DEF 14A | Act: 34 | File No.: 001-31577 | Film No.: 07793501
SIC: 2834 Pharmaceutical Preparations